L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own URGN

Urogen Pharma LTD in the Q2 2026 filings. At least 2 of the 91 current managers on file reported a position, worth $4.8m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
2
at least, of 91 current
Combined value
$4.8m
as reported
Opened
1
new this quarter
Added to
0
already held
Trimmed or sold out
2
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
ARK Investment Management LLC
Long-only · $15.4bn book
$3.7m0.0%101,508+$1.7m-14,037Trimmed
Polen Capital Management LLC
Long-only · $11.6bn book
$1.1m0.0%29,615opened29,615New

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 4 of the 95 managers whose filings are on file listed URGN in Q2 2026, against 1 in Q4 2017. 2 managers more than in Q1 2026: 2 started positions; 1 listed it again; 1 sold out, by its own filing.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
024Q4 2017: 1Q1 2018: 118Q2 2018: 1Q3 2018: 1Q4 2018: 1Q1 2019: 319Q2 2019: 1Q3 2019: 1Q4 2019: 2Q1 2020: 220Q2 2020: 2Q3 2020: 2Q4 2020: 1Q1 2021: 121Q2 2021: 1Q3 2021: 1Q4 2021: 1Q1 2022: 122Q2 2022: 1Q3 2022: 1Q4 2022: 1Q1 2023: 123Q2 2023: 1Q3 2023: 1Q4 2023: 1Q1 2024: 124Q2 2024: 3Q3 2024: 3Q4 2024: 1Q1 2025: 125Q2 2025: 1Q3 2025: 3Q4 2025: 3Q1 2026: 226Q2 2026: 4
  • Q4 2017: 1
  • Q1 2018: 1
  • Q2 2018: 1
  • Q3 2018: 1
  • Q4 2018: 1
  • Q1 2019: 3
  • Q2 2019: 1
  • Q3 2019: 1
  • Q4 2019: 2
  • Q1 2020: 2
  • Q2 2020: 2
  • Q3 2020: 2
  • Q4 2020: 1
  • Q1 2021: 1
  • Q2 2021: 1
  • Q3 2021: 1
  • Q4 2021: 1
  • Q1 2022: 1
  • Q2 2022: 1
  • Q3 2022: 1
  • Q4 2022: 1
  • Q1 2023: 1
  • Q2 2023: 1
  • Q3 2023: 1
  • Q4 2023: 1
  • Q1 2024: 1
  • Q2 2024: 3
  • Q3 2024: 3
  • Q4 2024: 1
  • Q1 2025: 1
  • Q2 2025: 1
  • Q3 2025: 3
  • Q4 2025: 3
  • Q1 2026: 2
  • Q2 2026: 4
Their combined reported value
$0$40m$79mQ4 2017: $345kQ1 2018: $671k18Q2 2018: $470kQ3 2018: $532kQ4 2018: $486kQ1 2019: $11m19Q2 2019: $486kQ3 2019: $339kQ4 2019: $7.9mQ1 2020: $5.8m20Q2 2020: $11mQ3 2020: $9.6mQ4 2020: $1.3mQ1 2021: $5.7m21Q2 2021: $4.8mQ3 2021: $4.1mQ4 2021: $1.8mQ1 2022: $2.9m22Q2 2022: $1.6mQ3 2022: $2.3mQ4 2022: $1.7mQ1 2023: $2.5m23Q2 2023: $2.1mQ3 2023: $3.0mQ4 2023: $2.4mQ1 2024: $2.2m24Q2 2024: $49mQ3 2024: $25mQ4 2024: $1.5mQ1 2025: $2.1m25Q2 2025: $2.3mQ3 2025: $16mQ4 2025: $15mQ1 2026: $2.3m26Q2 2026: $79m
  • Q4 2017: $345k
  • Q1 2018: $671k
  • Q2 2018: $470k
  • Q3 2018: $532k
  • Q4 2018: $486k
  • Q1 2019: $11m
  • Q2 2019: $486k
  • Q3 2019: $339k
  • Q4 2019: $7.9m
  • Q1 2020: $5.8m
  • Q2 2020: $11m
  • Q3 2020: $9.6m
  • Q4 2020: $1.3m
  • Q1 2021: $5.7m
  • Q2 2021: $4.8m
  • Q3 2021: $4.1m
  • Q4 2021: $1.8m
  • Q1 2022: $2.9m
  • Q2 2022: $1.6m
  • Q3 2022: $2.3m
  • Q4 2022: $1.7m
  • Q1 2023: $2.5m
  • Q2 2023: $2.1m
  • Q3 2023: $3.0m
  • Q4 2023: $2.4m
  • Q1 2024: $2.2m
  • Q2 2024: $49m
  • Q3 2024: $25m
  • Q4 2024: $1.5m
  • Q1 2025: $2.1m
  • Q2 2025: $2.3m
  • Q3 2025: $16m
  • Q4 2025: $15m
  • Q1 2026: $2.3m
  • Q2 2026: $79m

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Largest increases, by shares

Largest decreases, by shares

ManagerValue over timeFirst listedLargestQ2 2026
Point72 Asset Management LPQ1 2019$56m$56m
Woodline Partners LPQ2 2024$18m$18m
ARK Investment Management LLCQ4 2017$5.7m$3.7m
Polen Capital Management LLCQ2 2026$1.1m$1.1m
Voloridge Investment Management LLCQ3 2025$14mlast listed Q3 2025
Artisan Partners LPQ1 2020$9.4mlast listed Q3 2020
ExodusPoint Capital Management LPQ1 2019$451klast listed Q1 2019
Farallon Capital Management LLCQ3 2025$258klast listed Q1 2026

What URGN is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around URGN →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.